EMAIL DIGESTS
Daily
Every morning
Weekly
Sunday recap
Bluejay Therapeutics is a private biopharmaceutical company that specializes in developing curative treatments for viral infections and liver diseases, including CHB and CHD.
Mirum Pharmaceuticals to Acquire Bluejay Therapeutics, for Up To $820M
Fed Rate Cut Tailwind, Lilly’s Triple Agonist Delivers Big, Vaccine Policy Turmoil — This Week in Biotech #81
Mirum Acquires Bluejay, Adding Brelovitug Treatment for HDV
Mirum Pharmaceuticals to Acquire Bluejay Therapeutics for Up to $820M
Mirum Pharmaceuticals Acquires Bluejay Therapeutics, Adding Brelovitug for HDV